Bank Of America Corp Otonomy, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.72 - $2.51 $1 - $2	-1 Reduced 0.01%	7,140 $14,000
Q1 2022 May 16, 2022	BUY	$1.72 - $2.47 $10,908 - $15,664	6,342 Added 793.74%	7,141 $17,000
Q4 2021 Feb 08, 2022	SELL	$1.69 - $2.31 $966 - $1,321	-572 Reduced 41.72%	799 $2,000
Q3 2021 Nov 15, 2021	BUY	$1.22 - $2.2 $1,639 - $2,956	1,344 Added 4977.78%	1,371 $3,000
Q2 2021 Sep 13, 2021	BUY	$2.06 - $2.67 $55 - $72	27 New	27 $0

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.